Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, and What Factors Will Drive It?
The bioinformatics in in-vitro diagnostics (ivd) testing market has seen a robust expansion in recent years. Projected growth will see it rise from $93.02 billion in 2024 to $98.89 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to growth during the historic period include enhanced healthcare infrastructure, enlargement of biobanks, an increase in the elderly population, government funding and initiatives, and the development of personalized medicine.
Expectations are high for the bioinformatics in in-vitro diagnostics (ivd) testing market as it is predicted to witness robust growth in the coming years, scaling up to an impressive$126.76 billion by 2029 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth during the forecast period could be due to an increase in disease incidence rates, the integration of technology in healthcare, robust government initiatives and financial aid, a shift towards personalized medicine, improved understanding of the advantages of bioinformatics in diagnostics amongst healthcare professionals, and the reduction in the cost of genomic sequencing. The projection period is poised to see major advancements such as artificial intelligence (AI) and machine learning, next-generation sequencing, point-of-care (POC) testing, cloud computing and big data, along with breakthroughs in immunochemical techniques.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16629&type=smp
Which Primay Drivers Are Accelerating Growth in the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
The continual rise in cancer occurrences is predicted to fuel the expansion of the bioinformatics in IVD testing market. Cancer broadly refers to a multitude of diseases marked by abnormal cell growth, capable of invading and spreading throughout the body. The surge in cancer occurrences is attributable to an array of factors that include exposure, lifestyle, and environmental causes. The application of bioinformatics in IVD testing revolutionizes cancer diagnosis by offering accurate, individualized, and thorough genetic insights that improve early detection, the processes of choosing treatments, and patient results. For instance, in 2022, as per the National Association of Chronic Disease Directors (NACDD), a government agency based in the US, it had been found that around 40% of American adults live with multiple chronic conditions (MCC). There is a mounting evidence suggesting that having one chronic illness amplifies the risk of developing more, particularly with advancing age. Hence, the constant rise in cancer occurrences propels the growth of the bioinformatics in the IVD testing market.
Which Primary Segments of the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Are Driving Growth and Industry Transformations?
The bioinformatics in in-vitro diagnostics (ivd) testingmarket covered in this report is segmented –
1) By Type: Hardware; Software
2) By Type Of Test: Blood Based Tests; Tissue Based Tests
3) By Application: Cardiovascular Diseases; Chronic Diseases; Diabetes; Cancer; Other Applications
Subsegments:
1) By Hardware: Analyzers; Laboratory Equipment; Data Storage Devices; Sensors And Detectors; Workstations And Data Processing Hardware
2) By Software: Bioinformatics Platforms; Data Management and Integration Software; Analytics And Interpretation Software; Cloud-Based Software Solutions; AI-Based Software For Diagnostics
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16629&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?# Market?
North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Industry Dynamics?
Leading firms in the bioinformatics in the IVD testing market are increasingly focusing on the creation of innovative solutions such as next-generation sequencing (NGS) to augment detection and analysis of genetic abnormalities, refine diagnostic precision, and foster approaches in personalized medicine. NGS is a technology with a high-throughput, which facilitates instantaneous sequencing of entire genomes or targeted DNA and RNA regions, allowing for an exhaustive genetic inspection. For example, in May 2022, Illumina Inc., a biotech firm based in the US, presented a new pan-cancer companion diagnostic (CDx) indication for its TruSight Oncology Comprehensive (EU) test carrying the CE mark. This enables the test to identify cancer patients carrying solid tumors exhibiting neurotrophic tyrosine receptor kinase (NTRK) gene fusions such as NTRK1, NTRK2, or NTRK3, who might find targeted therapy with Bayer’s Vitrakvi (larotrectinib) beneficial. The TSO Comprehensive (EU) test is a comprehensive genomic profiling (CGP) assay that comprises next-generation sequencing which evaluates multiple tumor genes and biomarkers from a singular biopsy specimen, helpful in discerning a patient’s individual cancer molecular profile.
View the full report here:
What Parameters Are Used to Define the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
Bioinformatics in in vitro diagnostics (IVD) refers to the application of computational methods, data analysis, and software tools to interpret and analyze biological data generated from in vitro diagnostic tests. It involves using algorithms and statistical models to process large volumes of molecular and clinical data from diagnostic tests conducted outside the living organism (in vitro).
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16629
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model